← Back to Search

TeamTRACS Pilot (CTSI)

N/A

Waitlist Available

Led By Elizabeth A McGuier, PhD

Research Sponsored by University of Pittsburgh

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

* Individuals at least 18 years of age who are members of the multidisciplinary team at the participating CACs.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3-month follow-up (month 7, 3 months after training workshop)

Awards & highlights

No Placebo-Only Group

Summary

This trial tests a training program called TeamTRACS to help rural Child Advocacy Center teams work better together. The goal is to improve teamwork so these teams can provide better care for children who have experienced abuse.

Eligible Conditions

Teamwork
Implementation

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3-month follow-up (month 7, 3 months after training workshop)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3-month follow-up (month 7, 3 months after training workshop)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3-month follow-up (month 7, 3 months after training workshop) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Acceptability of Self-guided Implementation

Appropriateness of Self-guided Implementation

Change in Teamwork Knowledge From Baseline to 3-month Follow-up

+2 more

Secondary study objectives

Change in Team Functioning From Baseline to 3-month Follow-up: Learning Behavior

Change in Team Functioning From Baseline to 3-month Follow-up: Psychological Safety

Change in Team Performance From Baseline to 3-month Follow-up

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: TeamTRACS (Team Training in Roles, Awareness, Communication, and Support)Experimental Treatment1 Intervention

CACs randomized to the intervention condition (n = 4) will participate in TeamTRACS. CACs will receive an implementation guide to assist in preparing for and maximizing the impact of training.

Group II: Waitlist ComparisonActive Control1 Intervention

CACs randomized to the waitlist comparison (n = 2) will participate in TeamTRACS approximately 4 months after CACs in the intervention condition.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

TeamTRACS

2022

N/A

~180

0 / 1Eligibility criteria met